Language selection

Search

2009-02-24 - Female - 39 Years old

319147

Adverse reaction report number 319147
Latest AER version number 0
Market authorization holder AER number SPV1200900195
Initial received date 2009-02-24
Latest received date 2009-02-24
Age 39 Years
Gender Female
Weight N/A
Type of report Spontaneous
Reporter type Physician
Source of report MAH
Report outcome Not recovered/not resolved
Serious report? Yes

Reason for seriousness

Death
Disability
Cogenital anomaly
Life threateting
Hospitalization
Other medically important Yes

Product information

Product description Dosage form Health product role Route of administration Dose Frequency Therapy duration Indication(s)
ADDERALL XR 15MGCAPSULE, EXTENDED RELEASESuspectUnknown15 Milligram1 every 1 Day(s)631 Day(s)Attention deficit/hyperactivity disorder
ADDERALL XR 30MGCAPSULE, EXTENDED RELEASESuspectUnknown30 Milligram1 every 1 Day(s)631 Day(s)Attention deficit/hyperactivity disorder
AERIUSNOT SPECIFIEDConcomitantUnknown
ASANOT SPECIFIEDConcomitantUnknown
CITALOPRAMTABLETConcomitantUnknown
METFORMINTABLETConcomitantUnknown
SYNTHROIDNOT SPECIFIEDConcomitantUnknown

Adverse reaction term information

MedDRA version: v.21.1
Adverse reaction terms Reaction duration
Granulomatosis with polyangiitis
Limb discomfort
Nasal septum perforation
Pain
Paranasal sinus discomfort
Prescribed overdose
Raynaud's phenomenon
Soft tissue disorder
Vasculitis
Date modified: